Discovering the Power of Recombinant DNA Technology: Hepatitis B Vaccine Development and its Impact on Global Health

What was the first approved recombinant vaccine?

Hepatitis B in 1986 produced in S. cerevisiae

The first approved recombinant vaccine was the hepatitis B vaccine, which was developed in the 1980s using recombinant DNA technology. This vaccine is made by inserting the gene for a hepatitis B surface antigen into yeast cells, which then produce large amounts of the protein. The hepatitis B surface antigen is a protein that is found on the surface of the virus and is used by the immune system to identify and destroy the virus. By presenting this antigen to the immune system, the vaccine stimulates the production of antibodies that can protect against infection with the hepatitis B virus. The recombinant hepatitis B vaccine has been highly effective in preventing hepatitis B infection and is now a routine part of the childhood vaccination schedule in many countries around the world.

More Answers:

A Complete Guide to Antibiotics: How They Work and Why They Should be Used Responsibly.
The Fascinating World of Prokaryotes: Evolution, Classification, and Ecological Importance
Understanding Viruses: Structure, Replication, and Spread in Living Organisms

Error 403 The request cannot be completed because you have exceeded your quota. : quotaExceeded

Share:

Recent Posts

Mathematics in Cancer Treatment

How Mathematics is Transforming Cancer Treatment Mathematics plays an increasingly vital role in the fight against cancer mesothelioma. From optimizing drug delivery systems to personalizing

Read More »